|
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide Basic information |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide Chemical Properties |
density | 1.54±0.1 g/cm3(Predicted) | storage temp. | Sealed in dry,Store in freezer, under -20°C | solubility | DMSO:PBS (pH 7.2) (1:5):0.2(Max Conc. mg/mL);0.46(Max Conc. mM) Ethanol:3.0(Max Conc. mg/mL);6.96(Max Conc. mM) | pka | 9.51±0.50(Predicted) | form | White powder. | color | White to off-white |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide Usage And Synthesis |
Uses | LIMKi 3 is a LIM kinase 1 (LIMK1) inhibitor that has antitumor properties. | Definition | ChEBI: LimKi 3 is a member of the class of pyrazoles that is 1-(2,6-dichlorophenyl)-1H-pyrazole which is substituted by a difluoromethyl group at position 3 and by a 2-(isobutyrylamino)-1,3-thiazol-5-yl group at position 5. It is a a potent cell-permeable inhibitor of LIM kinase 1 and 2. It has a role as a LIM kinase inhibitor. It is a member of pyrazoles, a member of 1,3-thiazoles, a dichlorobenzene, an organofluorine compound and a secondary carboxamide. | storage | Store at +4°C |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide Preparation Products And Raw materials |
|